Stay updated on REGN3500 Efficacy/Safety/PK in Atopic Dermatitis Clinical Trial
Sign up to get notified when there's something new on the REGN3500 Efficacy/Safety/PK in Atopic Dermatitis Clinical Trial page.

Latest updates to the REGN3500 Efficacy/Safety/PK in Atopic Dermatitis Clinical Trial page
- Check3 days agoChange DetectedThe page shows a revision badge update from v3.6.6 to v3.7.0, signaling a minor software/format update. This change does not modify study text, data, or user-facing content.SummaryDifference0.0%

- Check10 days agoNo Change Detected
- Check17 days agoChange DetectedThe page's revision tag has been updated from v3.6.5 to v3.6.6, representing a small metadata update.SummaryDifference0.0%

- Check24 days agoChange DetectedThe study's 'Other Study ID Numbers' now includes '2018 ( U.S. NIH Grant/Contract )', indicating NIH funding attribution. This addition clarifies the funding source alongside other identifiers.SummaryDifference0.0%

- Check38 days agoChange DetectedThe page's revision label was updated from v3.6.4 to v3.6.5, indicating a new version of the page content.SummaryDifference0.0%

- Check52 days agoChange DetectedA Publications section was added to the study record, listing a PubMed-cited article related to itepekimab in atopic dermatitis and noting that publications are automatically filled from PubMed.SummaryDifference0.1%

- Check59 days agoChange DetectedThe page's revision label now shows Revision: v3.6.4, replacing the previous Revision: v3.6.3.SummaryDifference0.0%

Stay in the know with updates to REGN3500 Efficacy/Safety/PK in Atopic Dermatitis Clinical Trial
Enter your email address, and we'll notify you when there's something new on the REGN3500 Efficacy/Safety/PK in Atopic Dermatitis Clinical Trial page.